Generation Bio Co
NASDAQ:GBIO

Watchlist Manager
Generation Bio Co Logo
Generation Bio Co
NASDAQ:GBIO
Watchlist
Price: 1.83 USD -10.73% Market Closed
Market Cap: 122.1m USD
Have any thoughts about
Generation Bio Co?
Write Note

Generation Bio Co
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Generation Bio Co
Operating Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Generation Bio Co
NASDAQ:GBIO
Operating Income
-$138.6m
CAGR 3-Years
-20%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Income
$15.4B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Operating Income
$10.9B
CAGR 3-Years
-3%
CAGR 5-Years
20%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Operating Income
$6.2B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Income
$4.3B
CAGR 3-Years
17%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Income
$4.2B
CAGR 3-Years
-18%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is Generation Bio Co's Operating Income?
Operating Income
-138.6m USD

Based on the financial report for Dec 31, 2023, Generation Bio Co's Operating Income amounts to -138.6m USD.

What is Generation Bio Co's Operating Income growth rate?
Operating Income CAGR 5Y
-30%

Over the last year, the Operating Income growth was -2%. The average annual Operating Income growth rates for Generation Bio Co have been -20% over the past three years , -30% over the past five years .

Back to Top